Putting AVB recipes in context: why the active-ingredient dose remains unknown

What is AVB or ABV?

The device study by Lanz shows that the distribution of cannabinoids between collected vapour, residues, and losses depends on the device design. No general table can be derived from this that assigns a fixed residual content to browned plant material. Even the same user can produce different residues with different fills and draw patterns. A diagram showing the average result of a device study does not analyse a specific AVB sample.

Reading colour as a qualitative observation

Lighter, darker, or unevenly browned areas may offer hints about the degree of thermal treatment. They are not a quantitative potency analysis. Two samples that look identical may have started with very different THC contents. Moisture, lighting, and material composition also alter the visual impression of colour. For this reason, we replace percentage tables based on colour with the statement that reliable determination of residual content requires appropriate laboratory analysis.

The temperature display alone is also insufficient for back-calculation. What matters is which temperature was applied, for how long, and to which parts of the material. A prior session does not mean that complete decarboxylation or a defined level of extraction was achieved throughout. Statements such as ‘always fully activated’ or ‘dark brown equals five per cent’ are therefore not scientifically supportable.

Why grams of AVB are not a reproducible oral dose

A quantity expressed in grams describes the weight of the total residue. For an active-substance dose, the analysed cannabinoid content would also need to be known. An example calculation using an arbitrarily assumed residual content creates only an appearance of precision. This applies equally to self-blended batches: if the constituents are unknown, mixing them uniformly does not make the total composition known.

The shift from inhalation to oral intake also changes the time course. Human studies on edibles show delayed and variable absorption; effects and blood THC levels cannot be derived directly from prior vaporizer experience. These investigations were conducted with defined study preparations. They do not determine the potency of a particular AVB batch, nor a reliable ratio of grams of AVB to a previously inhaled draw.

Processing, hygiene, and the limits of recipe claims

Recipes can describe a culinary process, but without an analysed starting material they cannot specify a standardised active-substance quantity per serving. Water treatment, the addition of fat, or extended steeping do not make an unknown composition calculable. A change in colour or a milder smell equally do not prove the removal of unwanted substances. A claimed potency enhancement through a processing step would need to be substantiated with appropriate measurements.

A dry, unremarkable appearance does not guarantee microbiological quality. Moist, mould-affected, or otherwise suspect plant material should not be prepared for reuse. Where a cannabis-containing food product is present, clear labelling and storage out of reach of children and pets are essential. The studies cited below explain general pharmacokinetics; they are not an assessment of the shelf life or suitability of home-made products.

Residues are not a potency profile

The thermal history alone does not allow reliable conclusions that AVB consistently contains ‘more CBN’, a particular sedative effect, or a more favourable THC-to-CBD ratio. Changes depend on the material and conditions. Even an analytically confirmed change would still not constitute clinical evidence of efficacy. Detection of a substance, dosage, and actually observed effect remain separate questions.

For a fuller understanding, it is worth comparing decarboxylation and the evidence on different routes of administration. The critical limitation remains unchanged: recognising residue is straightforward; determining its pharmacological potency without measurement is not.

What an AVB recipe can actually deliver

A recipe typically describes ingredients, processing, and portioning. When the starting material contains cannabis, an additional question arises: how much active compound does the finished product actually contain? A kitchen instruction does not answer this question automatically. A reliably known ratio of ingredients cannot substitute for an unknown starting content. We therefore distinguish a reproducible kitchen process from a standardised medicinal preparation.

The number of portions alone does not resolve the problem either. It permits a calculated statement per portion only when the total content and its distribution are sufficiently well known. An uneven mix can introduce further variation. Visibly equal-sized pieces are therefore no proof of equal THC quantities. With an unknown AVB starting material, any quantitative assessment already fails before this distribution step.

Hidden assumptions in potency calculators

A calculator may operate with an assumed residual potency, an assumed transfer into the preparation, and an assumed uniform distribution. The arithmetic can be correct whilst the result remains unreliable. A neatly presented milligram figure does not turn unknown inputs into measured values. Particularly problematic is deriving the first assumption from a colour chart and then applying further ostensibly precise percentage factors on top of it.

For a scientifically honest presentation, assumed quantities must therefore be visibly distinguished from analysed values. Where the central input is missing, the statement “cannot be reliably determined” is more informative than a figure with decimal places. This applies equally to fat-based preparations, beverages, and other foodstuffs. The form of the final product does not eliminate the uncertainty of the starting material.

Why general edible studies do not validate AVB recipes

Human studies use defined study preparations. Their active compound quantities and procedures are far better characterised than those of any given home AVB batch. General differences between oral ingestion and inhalation can be derived from such studies. What cannot be derived, however, is the potency of a specific recipe, its uniform distribution, or a particular shelf life. Sources must therefore appear alongside only the claims they actually support.

A brownie trial is relevant, for example, to the time course of an oral THC dose. It does not automatically apply to every foodstuff that has likewise been baked. Product matrix, formulation, and individual absorption remain influential factors. Particularly in recipe content, this limitation prevents a reputable clinical source from being inadvertently used as a seal of approval for an untested process.

Storage and labelling

A cannabis-containing foodstuff should be clearly identifiable as such and stored separately from ordinary food. A product that looks normal to an outsider can otherwise be consumed accidentally. Access by children and pets must be prevented. This applies regardless of whether the AVB quantity used is subjectively considered small.

A self-written list of ingredients can document what was used; it is not a certificate of analysis and does not establish a reliable best-before date. Smell and appearance are likewise not a complete quality check. The fundamental questions about how AVB is produced and what residual content it contains are explained in the main AVB article. This page focuses on the additional uncertainties introduced by processing, portioning, and potency calculators.

Newmeyer MN, Swortwood MJ, Barnes AJ, Abulseoud OA, Scheidweiler KB, Huestis MA. 2016. Free and Glucuronide Whole Blood Cannabinoids’ Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake. Clinical chemistry. DOI: 10.1373/clinchem.2016.263475 · PMID 27899456

Monte AA, Shelton SK, Mills E, Saben J, Hopkinson A, Sonn B, Devivo M, Chang T, Fox J, Brevik C, Williamson K, Abbott D. 2019. Acute Illness Associated With Cannabis Use, by Route of Exposure: An Observational Study. Annals of internal medicine. DOI: 10.7326/M18-2809 · PMID 30909297 · PMC6788289